Cytokines
Cytokines are the immune system's own signalling proteins — chiefly interferons and interleukins — given in laboratory-made form to strengthen the body's response against cancer; NCI classifies them among immune system modulators. Interferon alfa activates certain white blood cells, while interleukin-2 (IL-2) increases the numbers of killer T cells and natural killer cells. They were among the earliest immunotherapies and are today used mostly in advanced cancers; flu-like symptoms are common, and high doses can affect blood pressure and organ function.
How it works
Used in
Interleukin-2 (aldesleukin) is approved for melanoma that has metastasised [NCI]. It is one of the older immunotherapies, in clinical practice largely superseded by checkpoint inhibitors; any use is decided by the treating team.
Interleukin-2 (aldesleukin) is approved for renal cell carcinoma that has metastasised [NCI]. As in melanoma, this is an older treatment, today used less often than checkpoint immunotherapy and targeted agents.